Open AccessHypertension due to juxtaglomerular cell tumor of the kidney
Author(s) -
Wu Tao,
Gu JunQing,
Duan Xi,
Yu XiaoDong
Publication year - 2016
Publication title -
the kaohsiung journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.439
H-Index - 36
eISSN - 2410-8650
pISSN - 1607-551X
DOI - 10.1016/j.kjms.2016.03.005
Subject(s) - medicine , hypokalemia , renal hilum , blood pressure , kidney , secondary hypertension , juxtaglomerular apparatus , renal function , hypertensive heart disease , cardiology , heart failure , nephrectomy , renin–angiotensin system
A juxtaglomerular cell tumor (JGCT) is a very rare cause of hypertension that was first described by Robertson et al [1]. Patients have hypertension, hyperaldosteronism, and hypokalemia secondary to tumor renin secretion [2], and the hypertension usually returns to normal immediately or gradually after tumor removal. Here, we report a case of JGCT of the kidney with serious cardiovascular complications that was misdiagnosed for nearly 10 years. A 62-year-old female was admitted to the Department of Cardiovascular Surgery at our hospital with severe hypertension, hypertensive heart disease, and pulmonary infection. She had persistent high blood pressure (BP; 180 110 mmHg, grade III hypertension) with a personal history of elevated BP for almost 10 years. She took overthe-counter captopril following diagnosis of hypertension 10 years ago, but she was unable to detail drug dosage or how well it controlled her BP. Doppler echocardiography showed left atrium and ventricle hypertrophy, and the